05 Compliance

The regulatory file for L-proline

Technical document 05 · Reviewed 2026-11-19 · L-Proline

On this page
  1. What the regulatory file contains
  2. The European Union
  3. The United States
  4. Great Britain and Northern Ireland
  5. Contaminant limits and the daily dose
  6. Claims and the label
  7. Documents the file must hold
  8. Checklist before the first order

L-Proline is an amino acid, CAS 147-85-3. The regulatory file has to show the exact form, the route the buyer relies on for the destination, the contaminant calculation for the finished dose and the label wording. This page lists the instruments and documents that belong in the file; it does not decide permission for a market. The buyer's regulatory team owns that decision.

In one line

An amino acid can enter a market as a food ingredient, a supplement ingredient or an additive, and the file has to name the route the buyer relies on.

What the regulatory file contains

A usable file answers four questions: what the material is and which specification version is being bought; which lot is being released and what its certificate reports; which route and limits apply in the destination; and what happens when the source, the process or the pack changes. The certificate covers the lot, the technical data sheet the specification, and the safety data sheet the handling. None of them decides the route.

For an amino acid the route question is real: the same powder can be sold as a food ingredient, a supplement ingredient, an additive or a flavouring, and the instruments differ. The file should name the route rather than leave it implicit; the specification with L-proline, CAS 147-85-3 and the rotation window is the common starting point.

Instruments to check for an amino-acid ingredient
MarketMain instrumentsWhat they settle
European UnionRegulation (EC) No 178/2002; Regulation (EU) No 1169/2011; Regulation (EU) 2023/915; Directive 2002/46/EC; Regulations (EC) No 1333/2008 and No 1334/2008General food law, labelling, contaminants, supplement status, and the additive and flavouring routes
United StatesFD&C Act as amended by DSHEA; 21 CFR 111; 21 CFR 101.36; the food-additive or GRAS route where the use is a food ingredientDietary ingredient status, cGMP, Supplement Facts, and food use
Great BritainRetained food law, GB labelling rules and the GB novel food register; Northern Ireland follows the EU frameworkPermission and labelling for the destination

This is a sourcing reference, not legal advice; the current text and the buyer's own review decide.

The European Union

General food law sets the safety obligation, and Regulation (EU) No 1169/2011 sets the labelling particulars. Contaminants are governed by Regulation (EU) 2023/915 as amended. Food supplements fall under Directive 2002/46/EC, whose Annexes list the vitamins and minerals permitted in supplements; an amino acid is not on those lists, so the level and notification rules come from general food law and the member state where the product is sold. The buyer's team confirms the position for the destination.

Two further routes apply if the use is not a supplement. Where proline is used as an additive, Regulation (EC) No 1333/2008 and its Union list apply; where it is used as a flavouring, Regulation (EC) No 1334/2008 applies. A novel-food check under Regulation (EU) 2015/2283 belongs as a documented position. As of this review the consolidated texts are the reference, and member-state practice is part of the answer.

The United States

The supplement route runs through the FD&C Act as amended by DSHEA. The manufacturer must test the identity of each component under 21 CFR 111, and the Supplement Facts panel is set by 21 CFR 101.36. The supplier's file should support the identity of L-proline: name, CAS number, IR and HPLC identity, and the rotation.

If the intended use is a conventional food rather than a supplement, the food-additive or GRAS route applies, and the buyer confirms the basis. A structure or function statement is possible on the supplement route if it is truthful, substantiated and accompanied by the DSHEA disclaimer in 21 CFR 101.93; a disease claim is not. The label and any claim are checked apart from the certificate.

Great Britain and Northern Ireland

Great Britain and Northern Ireland follow different routes. The GB file uses retained food law, GB labelling rules and the GB novel food register; Northern Ireland sits under the EU framework. Which one applies is for the buyer's regulatory team to confirm. An EU file does not automatically answer the GB question.

Contaminant limits and the daily dose

The catalog limits are specification terms, not the destination's finished-product limit. The file needs the lot result, the method, the limit and the arithmetic to the daily dose.

Catalog limits and what the file should show
ParameterCatalog limitWhat the file shows
Lead (Pb)≤3 mg/kgLot result, method and the finished-product calculation
Cadmium (Cd)≤1 mg/kgLot result and any exception for the category
Mercury (Hg)≤0.1 mg/kgLot result and method
Arsenic (As)≤2 mg/kgThe agreed limit, the method and the destination rule

A lot released at the catalog limit leaves no analytical margin: if the daily dose is high, or another ingredient adds the same metal, the supplement can exceed the destination's limit even though the powder passed. The arsenic line is contractual in many markets; check whether the destination sets a maximum. The calculation belongs to the finished product, not only to the drum.

Claims and the label

In the EU and the UK, health claims are governed by Regulation (EC) No 1924/2006 and its retained equivalents, and a claim has to be authorised before it is used. Compositional statements are a different category: “L-proline 500 mg per capsule” describes the product, and the figure must match the certificate. In the US, the structure or function route rests on the brand's substantiation and carries the disclaimer; a disease claim is not available on either route.

The certificate cannot approve a claim, and a claim cannot alter the specification. The brand's reviewer checks the wording for the market, the form and the dose. This page makes no therapeutic or disease-related claim.

Documents the file must hold

  • A batch certificate with the method and basis for each result, and a lot code that matches the pack.
  • The versioned specification, naming L-proline, the CAS number, the assay basis and the rotation window.
  • A safety data sheet, an allergen statement and a GMO statement for the material and the pack.
  • A site and country-of-origin statement naming the producer; a BSE/TSE statement for an animal-derived route and a non-animal statement for a fermentation route.
  • A residual-solvent statement and a food-contact declaration for the pouch and liner.
  • A stability summary, the assigned retest period and any halal or kosher certificate the market needs.
  • Any destination-specific declaration the importer requires, with its version and date.

Checklist before the first order

  1. Name the market and, in the EU, the member state of sale.
  2. Name the route: food ingredient, supplement ingredient, additive or flavouring.
  3. Confirm that the specification and the label both say L-proline, not DL-proline.
  4. Convert the contaminant limits to the daily dose and write down the margin.
  5. Check the destination's level, notification and novel-food position, not only the EU text.
  6. Review the claim wording against the register or the US substantiation file.
  7. Keep the specification, certificate and label on the same version and lot code.

The catalog specification is on the product page; the COA page walks through the lot certificate; the identity page sets out the analytical evidence; the quality page describes the release file.

Send the specification you intend to use — grade, quantity and destination market — and we will reply with the batch COA, the technical data sheet and a quotation.

Request a quotation